Galderma Announces the Launch of FACE by Galderma™ – a Game-Changing Augmented Reality Solution Helping Healthcare Professionals Grow Their Activity and Improve Patient Satisfaction - Yahoo Finance

• FACE by Galderma™ is simply a cutting-edge aesthetic visualization exertion that simulates the results of injectable treatments successful existent time, utilizing integer facial assessment

• The exertion provides precocious wrinkle detection arsenic good arsenic the imaginable results of 19 injectable treatments, which are displayed arsenic dynamic "before and after" images

• The solution offers a holistic attack to individualized care, empowering patients to prosecute their attraction program with confidence

• In a planetary aviator study, 80% of respondents said the exertion helped them to recognize their attraction options. Meanwhile, 85% stated that they would urge the application, and 91% said they program to instrumentality to their practitioner to proceed their attraction plan¹

ZUG, Switzerland, January 26, 2023--(BUSINESS WIRE)--Galderma has announced the motorboat of FACE by Galderma™, an innovative augmented world application. The ground-breaking solution enables aesthetic practitioners and patients to visualize attraction results astatine the readying stage. The exertion volition beryllium presented to the aesthetic technological assemblage astatine the International Master Course connected Aging Science (IMCAS) World Congress 2023 successful Paris connected January 26-28.

FACE by Galderma™ gives patients a real-time, realistic "before and after" presumption of imaginable results from an individualized attraction plan. This helps code concerns astir extremity results portion besides enabling amended knowing of a holistic attraction approach, yet starring to greater diligent satisfaction¹.

FACE by Galderma™ allows for an immersive, afloat interactive consultation process and enables the aesthetic practitioner to measure the full look successful existent time. The appraisal is based connected Galderma’s Five Facet Assessment that considers tegument quality, facial shape, facial symmetry, facial proportions, and contour, arsenic good arsenic animation and affectional expression. Following the assessment, precedence areas tin beryllium identified, and an individualized attraction program tin beryllium created. By taking a full-face approach, FACE by Galderma™ ensures that the practitioner provides a holistic attraction program that meets the patient’s needs. The exertion down FACE by Galderma™ was developed successful concern with Crisalix, the worldwide starring notation successful 3D, virtual world and augmented world aesthetic simulation.

The results of a caller planetary aviator survey of FACE by Galderma™ were highly promising. Of the respondents, 80% said the exertion helped them to recognize their attraction options, portion 73% agreed that it made them contemplate a process they had not antecedently considered. Meanwhile, 61% stated that they program to amusement their "before and after" images to friends. Overall, 85% said they would urge the application, and 91% said they program to instrumentality to their practitioner to proceed their individualized attraction plan¹.

FACE by Galderma™ features 19 imaginable injectable results utilizing products from the Galderma portfolio (depending connected section indications), enabling patients to spot simulated visuals successful existent time. Treatment options include:

• Neuromodulators, specified arsenic DYSPORT^®, AZZALURE^® (EU) and ALLUZIENCE^® (the archetypal ready-to-use liquid botulinum toxin benignant A, approved successful June 2021 for usage successful Europe (excluding Greece, Lithuania, Estonia, Latvia and Hungary)).

• Biostimulators, including SCULPTRA^®

• Products from the hyaluronic acerb filler range, RESTYLANE^® and RESTYLANE^® SKINBOOSTERS

The instrumentality besides facilitates diligent management, acting arsenic a "patient passport." It enables clinics to store each diligent records successful 1 place, including the attraction plan, "before and after" video and images, and assignment schedules. Patients tin besides entree their FACE by Galderma™ relationship and presumption their idiosyncratic diligent illustration from home.

FACE by Galderma™ volition beryllium disposable successful the United States and Brazil successful the archetypal fractional of 2023, with a planetary rotation retired crossed Latin America, Europe, Middle East, Canada and Asia passim 2023.

About Galderma
Galderma is the pure-play dermatology class leader, contiguous successful astir 90 countries. We present an innovative, science-based portfolio of premium flagship brands and services that spans the afloat spectrum of the fast-growing dermatology marketplace done Injectable Aesthetics, Dermo-cosmetics and Therapeutic Dermatology. Since our instauration successful 1981, we person dedicated our absorption and passionateness to the quality body’s largest organ – the tegument – gathering idiosyncratic user and diligent needs with superior outcomes successful concern with healthcare professionals. Because we recognize that the tegument we’re successful shapes our lives, we are advancing dermatology for each tegument story. For much information: www.galderma.com

About Crisalix
Crisalix is the online planetary simulation & imaging modular for Before & After aesthetic, reconstructive oregon tegument treatments, supporting healthcare professionals and educating patients connected their options. Thanks to our disruptive online imaging solution, powered by state-of-the-art Artificial Intelligence and Computer Vision techniques, our exclusive level is utilized by patients, starring aesculapian aesthetic brands and the astir recognized aesculapian providers passim the afloat diligent journey. With unbeaten cardinal improvements connected the main aesculapian information and related concern metrics, we absorption to heighten the quality travel of radical astir the world, time aft day, with crippled changing 3D, 4D, Virtual Reality and Augmented Reality visualization.

About Alluzience^® (liquid botulinum toxin benignant A)
Alluzience (liquid botulinum toxin benignant A) is the archetypal ready-to-use BoNT-A liquid neuromodulator formulation to beryllium introduced successful Europe. Alluzience should lone beryllium administered by a doc with due qualifications and expertise successful this attraction utilizing the required equipment.² Dosing and attraction intervals beryllium connected appraisal of the idiosyncratic patient’s response.² The attraction interval should beryllium nary much predominant than each 3 months.² For much information, delight spot the Summary of Product Characteristics.²

Alluzience is simply a merchandise nether licence from Ipsen. Alluzience is simply a registered trademark of Ipsen. Galderma has an exclusive licence from Ipsen to develop, beforehand and administer Alluzience successful the approved denotation successful respective European countries.

About Dysport^® / Azzalure^®
Dysport (abobotulinumtoxinA) is simply a medicine injection for impermanent betterment successful the quality of mean to terrible frown lines betwixt the eyebrows (glabellar lines) successful adults little than 65 years of age. Dysport is besides marketed arsenic Azzalure³ successful the EU for the attraction of glabellar lines and lateral canthal lines. Dysport has much than 30 years of objective acquisition globally for therapeutic indications and 13 years for aesthetics indications, with extended objective grounds of information and efficacy. It is licensed for aesthetic indications successful 85 markets worldwide, Dysport is 1 of the world’s starring brands of aesthetic neuromodulators with implicit 100 cardinal treatments delivered successful the aesthetics indications to date.

Dysport is simply a merchandise nether licence from Ipsen and is manufactured by them. Since 2009, Galderma and Ipsen person had a strategical concern nether which Galderma has promoted and distributed Ipsen’s botulinum toxin benignant A products successful aesthetic indications. The Ipsen-Galderma strategical concern present covers China, the United States, Europe and the Middle East, Australia, South Korea, Canada, Brazil, Argentina and definite different countries. Ipsen continues to beforehand Dysport wrong definite therapeutic indications successful countries astir the world. For much accusation connected Ipsen, sojourn www.ipsen.com.

About Restylane^®
RESTYLANE is the archetypal non-animal stabilized hyaluronic acerb filler with implicit 25 years of accomplishment and implicit 50 cardinal treatments worldwide. NASHA™ and OBT™ technologies marque RESTYLANE the world’s astir divers scope of fillers to present genuinely individualized results.^4,5

The RESTYLANE^® portfolio of products includes RESTYLANE^®, RESTYLANE^® LYFT™, RESTYLANE^® KYSSE™, RESTYLANE^® VOLYME™, RESTYLANE^® DEFYNE™, RESTYLANE^® REFYNE™, RESTYLANE^® EYELIGHT™ and RESTYLANE^® SKINBOOSTERS VITAL™.

About Sculptra^®
SCULPTRA works to stimulate the skin’s ain collagen production⁶ and is suitable for expanding the measurement of depressed areas, peculiarly to close tegument depressions specified arsenic tegument creases, wrinkles, folds, and scars, and for signs of tegument aging.⁷ SCULPTRA is besides suitable for ample measurement corrections of the signs of facial abdominous nonaccomplishment (lipoatrophy).⁷

SCULPTRA is an injectable biostimulator containing microparticles of poly-L-lactic acerb (PLLA) which gradually revitalizes the skin’s structural foundation, providing natural-looking, semipermanent results for up to 25 months.⁸ SCULPTRA was archetypal approved successful 1999 successful Europe and it is presently disposable successful much than 40 countries globally.

References
1. FACE App Patient Pilot Study, November 2020 – September 2021.170 patients' surveys from 12 countries
2. Alluzience Summary of Product Characteristics, 10 June 2021
3. Azzalure SmPC
4. Data connected record (MA-33939)
5. Öhrlund A. Poster presented astatine AMWC 2019
6. Bohnert K et al. Plast Reconstr Surg 2019;127(4):1684–92
7. Sculptra IFU. 2018
8. Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92

View root mentation connected businesswire.com: https://www.businesswire.com/news/home/20230125005814/en/

Contacts

Media
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Rachel Mooney
Global Franchise Communications
rachel.mooney@galderma.com
+41 76 261 64 41

Sébastien Cros
Corporate Communications Director
sebastien.cros@galderma.com
+41 79 529 59 85